ANDA 207236, held by Lannett Co Inc. Memantine Hydrochloride.
As of Nov 15, 2026, ANDA 207236 (Memantine Hydrochloride), held by Lannett Co Inc, was first approved by FDA on Nov 10, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 10, 2016 | Original application | Approved | None posted |
| Memantine Hydrochloride5MG · tablet;oral | Memantine Hydrochloride | Discontinued |
| Memantine Hydrochloride10MG · tablet;oral | Memantine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
